Lidings’ managing partner Andrey Zelenin heading the firm’s Pharmaceuticals and Healthcare industry practice and partner Boris Malakhov, Head of the Intellectual Property practice of the firm, run a special webinar on the key market developments in the healthcare and life sciences sector in Russia.

Starting from the beginning of 2021, new rules for the retail sale of goods (the “Rules”) entered into force. The Rules will be valid until January 1, 2027. The Rules are developed within the framework of the regulatory guillotine and replace a few previously existing documents (rules for retail trade, rules for distance selling of goods, rules for commission trading).

On January 5, 2021 the Decree of the Government of the Russian Federation No. 3718-r dated December 31, 2020 (the Decree) was published. In accordance with the Decree, Pharmasintez JSC, a Russian generic company, has been granted a 1-year compulsory license to use the inventions of the US companies Gilead Sciences Inc. and Gilead Pharmasset LLC protecting Remdesivir subject to a “fair compensation”¹.

One month after adopting Practice Review No. 3, the Presidium of the Supreme Court on December 23, adopted the next (fourth) review for the year 2020.

Federal Law No. 407-FZ dated December 8, 2020 made material amendments to the section of the Labor Code of the Russian Federation which regulates distance work. The necessity for such amendments became evident as soon as employers started to switch their staff to work from home in large numbers at the beginning of 2020.

Lidings signed Collaboration Agreement with Andersen Global, an international association of legally separate, independent member firms comprised of more than 6 000 tax and legal professionals around the world.

Starting from 2021, the amendments to the Labor Code regarding the regulation of labor in non-commercial (non-profit) organizations have come into force.

Country-specific Q&A provides an overview of Pharmaceutical Advertising laws and regulations applicable in Russia.

• pdf, 3.18 Mb